Home › Studies › PRJEB38742
PRJEB38742 ERP122188

Gut metagenome in imidazole propionate & diabetes (MetaCardis)

Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

Shotgun metagenomic sequencing of gut DNA from 1,018 participants (France, Denmark, Germany) in the MetaCardis cohort, spanning cardiometabolic disease, type 2 diabetes, obesity and healthy controls, to examine microbial imidazole propionate production. machine-written summary

1,018 samples · 5,024 runs · FR, DK, DE · Age unknown · 2020 · 2.95 Gbp / sample · cohort Evidence of a causal and modifiable relationship b

Sources
✓Sequence archive 551○Abstract / description✓Full text 2,036✓Supplementary tables 5,706–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive551 sample values (country)
○ Abstract / descriptionread; no usable statement
✓ Full text2,036 sample values (antibiotic exposure, collection date) · PMC10511707, PMC12363224, PMC12795280, PMC13079829, PMC13172010, PMC13377033, PMC7676231, PMC8863577, PMC9664128
✓ Supplementary tables5,706 sample values (age, bmi, country, health condition, health condition detail, medication, medication detail, sex)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
3 countries
Age
unknown573
adult260
elderly185
Condition
cardiometabolic_other603
type2_diabetes213
obesity157
healthy_control1
Sex
male368
female99
Country
FR455
DK294
DE269
Body site
primary1,018
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 596 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 421 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 1 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 2.95 Gbp per sample0130Gbp
Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category445 44%
country1,018 100%551467
health_condition974 96%974
subject_id974 96%974
antibiotic_exposure1,018 100%1,018
collection_date1,018 100%1,018
health_condition_detail974 96%974
age_at_collection_days467 46%467
sex467 46%467
medication462 45%462
medication_detail462 45%462
bmi459 45%459
Papers (12)
  • Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. 2020 PMID 33208748 PMC7676231 unsure
  • Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. 2022 PMID 35017197 PMC9664128 unsure
  • Microbiome and metabolome features of the cardiometabolic disease spectrum. 2022 PMID 35177860 PMC8863577 unsure
  • Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide. 2023 PMID 37730687 PMC10511707 unsure
  • Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes. 2024 PMID 38918632 PMC11620793 unsure
7 more
  • Metagenomic estimation of absolute bacterial biomass in the mammalian gut through host-derived read normalization. 2025 PMID 40742180 PMC12363224
  • Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes. 2025 PMID 41408736 PMC12795280
  • A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases. 2026 PMID 41786749 PMC13079829
  • CroCoDeEL: accurate control-free detection of cross-sample contamination in metagenomic data. 2026 PMID 42103726 PMC13377033
  • Network topology of the gut microbiome associates with metabolic health in obesity. 2026 PMID 42129189 PMC13172010
  • A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases. 2025
  • Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamineN-oxide with implications for heart and kidney disorders 2022
Details
Archive description

Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by curator_audit with confidence 0.60. Assay shotgun_dna.

  • host runs.scientific_name · “human gut metagenome (5024)”
  • host biosample_attributes.human_gut_environmental_package · “human-gut (1018)”
  • body site runs.scientific_name · “human gut metagenome (5024)”
  • body site biosample_attributes.human_gut_environmental_package · “human-gut (1018)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA7288155age_at_collection_days20819.2R20.85paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST9!Age (years)]Age (years) 57
SAMEA7288155antibiotic_exposurenoR30.70paper.body.methodsthat had received a recent antibiotic treatment (<2 months) were not included
SAMEA7288155bmi27.72R20.85paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST9!BMI (kg/m²)]BMI 27.71967
SAMEA7288155collection_date2013/2015R30.70paper.body.methodsSubjects were recruited between 2013 and 2015
SAMEA7288156countryFRR10.70sample.name_rule:aliasM0x10MCx1138
SAMEA7288155countryFRR20.85paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST9!Nationality]Nationality France
SAMEA7288155health_conditioncardiometabolic_otherR20.85paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST9!Status]Status MMC269|MMC372
SAMEA7288155health_condition_detailmetabolically matched control (matched to IHD on T2D status and BMI); diabetic status YesR20.85paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST9!Status]Status MMC269|MMC372; Diabetic status Yes
SAMEA7288155medicationantidiabetic_other;metforminR20.80paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST14!drug columns]Antidiabetic drugs; Insulin; Metformin; DPP IV inhibitors
SAMEA7288155medication_detailAntidiabetic drugs; Insulin; Metformin; DPP IV inhibitorsR20.80paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST14!drug columns]Antidiabetic drugs; Insulin; Metformin; DPP IV inhibitors
SAMEA7288155sexmaleR20.85paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST9!Gender]Gender Male
SAMEA7288155subject_idx10MCx1135R20.85paper.supp.41591_2022_1688_MOESM3_ESM.xlsx[ST9!ID]x10MCx1135
Sequencing

5,024 runs over 1,018 samples · mean 0.62 Gbp per run (median 0.60 Gbp, total 3,127.15 Gbp; 5,024 runs with a base count) · layout SINGLE 5,024 · platform ION_TORRENT 5,024 · models Ion Torrent Proton (5,024) · 0% of runs with a Sandpiper profile · first public 2020-09-03

Authors (128)

Tang G first · Carr AV · Perez C · Ramos Sarmiento K · Levy L · Lampe JW · Diener C · Gibbons SM last · Chechi K first · Chakaroun R · Myridakis A · Forslund-Startceva SK · Fromentin S · Nielsen T · Aron-Wisneswky J · Belda E · Prifti E · Lassen PB · Falony G · Vieira-Silva S · Chilloux J · Sonomura K · Hoyles L · Martinez-Gili L · Pallotti F · Andrikopoulos P · Puig-Castellví F · Tapia RP · Castro-Dionicio I · Roume H · Pons N · Le Chatelier E · Quinquis B · Galleron N · Berland M · Olanipekun MT · Jia M · Manolias A · Holmes B · Adriouch S · Blüher M · Coelho LP · Da Silva K · Galan P · Ji B · Neves AL · Rouault C · Salem JE · Tremaroli V · Hansen TH · Søndertoft NB · Lewinter C · Pedersen HK · MetaCardis Consortium · Mark PD · Goetze JP · Køber L · Vestergaard H · Hansen T · Zucker JD · Sato TA · Hercberg S · Bäckhed F · Letunic I · Oppert JM · Nielsen J · Raes J · Tzoulaki I · Dehghan A · Zuber V · Bouzigon E · Lathrop M · Raina P · Froguel P · Matsuda F · Demenais F · Gauguier D · Stumvoll M · Bork P · Pedersen O · Ehrlich SD · Clément K · Dumas ME last · Goulet L first · Plaza Oñate F · Famechon A · Gautreau G last · Lacruz-Pleguezuelos B first · Pérez-Cuervo A · Coleto-Checa D · Bazán GX · Romero-Tapiador S · Freixer G · Fernández-Cabezas J · Aguilar-Aguilar E · Martín-Segura A · Cárdenas-Roig N · Carrasco-Guijarro L · Fernández LP · Espinosa-Salinas I · Ramírez de Molina A · Morales A · Tolosana R · Ortega-Garcia J · Pancaldi V · Marcos-Zambrano LJ · Carrillo de Santa Pau E last · Schroer HW first · Beghini F · Raygoza Garay JA · Christakis NA · Bosch DE last · Aron-Wisnewsky J · Forslund SK · Salem J · Andreelli F · Kieswich J · Puig-Castellvi F · Chevalier M · Alves R · Helft G · Isnard R · Pedro Coelho L · Gøtze JP · Zucker J · Oppert J · Yaqoob MM · Dumas M last

Downloads

PRJEB38742.csv.gz (36.3 KB) · parquet (126.7 KB) — all 1,018 samples, every field with route and confidence · PRJEB38742_determinations.csv.gz (88.9 KB) — 8,293 evidence rows

Samples (1,018 · every field this project has values for · hover a cell for its source)
Loading the sample table…